Clinical Trials Browser

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Fatigue, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasm Metastasis, Oligodendroglioma, Pinealoma, Radiation Injuries, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

NCT03393000 2021-07-22

INTACT

Phase 3 Terminated

19 enrolled 8 charts

CNS

Glioblastoma

NCT04829097 2021-04-02

Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma

Phase 3 Unknown

80 enrolled

CNS

Glioblastoma

NCT01290939 2021-02-15

Bevacizumab and Lomustine for Recurrent GBM

Phase 3 Completed

592 enrolled

CNS

Brain Neoplasms, Cognition Disorders, Glioblastoma

NCT01507506 2021-01-12

SPECTRO GLIO

Phase 3 Terminated

180 enrolled

CNS

Glioblastoma

NCT04536649 2020-09-02

Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.

Phase 3 Unknown

369 enrolled

CNS

Glioblastoma

NCT01805453 2020-05-08

ASTER

Phase 3 Completed

80 enrolled

CNS

Edema, Glioblastoma

NCT04277221 2020-03-17

ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)

Phase 3 Unknown

118 enrolled

CNS

Glioblastoma

NCT03722355 2019-11-12

Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

Phase 3 Completed

712 enrolled

CNS

Astrocytoma, Glioblastoma, Glioma

NCT00884741 2019-07-24

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Phase 3 Completed

637 enrolled 11 charts

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT02511405 2018-10-23

GLOBE

Phase 3 Completed

252 enrolled

CNS

Glioblastoma

NCT03633552 2018-08-16

Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma

Phase 3 Unknown

62 enrolled

CNS

Astrocytoma, Glioblastoma

NCT01765088 2018-02-23

A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas

Phase 3 Unknown

300 enrolled

CNS

Astrocytoma, Glioblastoma, Glioma

NCT02629757 2018-02-23

β-elemene

Phase 3 Unknown

100 enrolled

CNS

Astrocytoma, Glioblastoma, Glioma

NCT01480479 2018-01-16

ACT IV

Phase 3 Completed

745 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Gliosarcoma

Clinical Trials

StrateGlio

EF-41

IPAX BrIGHT

SIGMA

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

BRIDGES

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

LEGATO

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

BrainUS-AI

Tofacitinib in Recurrent GBM Patients

SONOBIRD

Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

RESECT

STAR-3

MIRAGE

Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma

CSCRGBM

Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

THREE-GLEES

A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme

Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy

Intellance1

RE-GEND

FLEGME

A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme

HIT-HGG-2013

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

INTACT

Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma

Bevacizumab and Lomustine for Recurrent GBM

SPECTRO GLIO

Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.

ASTER

ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)

Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

GLOBE

Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma

A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas

β-elemene

ACT IV